drugset / Trial / NCT01668823
Photodynamic Therapy in Treating Patients With Lung Cancer
Phase 1
Completed
17 enrolled
Roswell Park Cancer Institute
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
This phase I trial is studying the side effects and best dose of photodynamic therapy using HPPH in treating patients with lung cancer. Photodynamic therapy uses a drug, such as HPPH, that becomes active when it is exposed to a certain kind of light. When the drug is active, cancer cells are killed.
Timeline
- Start
- 2004-02
- Primary completion
- 2013-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 2-[ 1-hexyloxyethel]-2-devinyl Pyropheophorbide-a | Unknown | — | Intravenous |